Pill to reduce COVID-19 hospitalizations and deaths


DOTHAN, Ala. (WDHN) — A new drug by drug maker, Merck, is said to significantly reduce COVID-19 hospitalizations and deaths.

While all other COVID treatments are administered through an injection or IV, this is the first oral antiviral pill used to fight against the virus.

This drug is not a replacement for the COVID-19 vaccine but is meant to be used to reduce symptoms once you have contracted the virus.

As Dr. Landers from the Alabama Department of Public Health says, it is still better to not contract the disease at all.

“I still remind people, not everyone is going to be eligible for the treatment,” Dr. Landers said. “The treatment is not going to be effective in every person, and it’s certainly better to not contract the disease.”

As of right now, the drug is not approved by regulators for use, but Merck plans to seek approval from the U.S. FDA soon.

Copyright 2021 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Trending Stories